These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
280 related items for PubMed ID: 1721983
1. Clinical efficacy of carvedilol in severe hypertension. Ogihara T, Yoshinaga K, Kamahara Y, Ikeda M, Goto Y, Arakawa K, Iimura I, Ishii M, Kokubu T, Takeda T. J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S69-72. PubMed ID: 1721983 [Abstract] [Full Text] [Related]
2. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients. Deetjen A, Heidland A, Pangerl A, Meyer-Sabellek W, Schaefer RM. Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935 [Abstract] [Full Text] [Related]
3. A multicenter comparison of carvedilol with hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension. Langdon CG, Baxter GA, Young PH. J Cardiovasc Pharmacol; 1991 Jan; 18 Suppl 4():S51-6. PubMed ID: 1721980 [Abstract] [Full Text] [Related]
4. Dose-effect relationship of carvedilol in essential hypertension. An open study. Ogihara T, Goto Y, Yoshinaga K, Kumahara Y, Iimura O, Ishii M, Murakami E, Takeda T, Kokubu T, Arakawa K. Drugs; 1988 Jan; 36 Suppl 6():75-81. PubMed ID: 2908305 [Abstract] [Full Text] [Related]
5. Pharmacokinetics and efficacy of carvedilol in chronic hemodialysis patients with hypertension. Miki S, Masumura H, Kaifu Y, Yuasa S. J Cardiovasc Pharmacol; 1991 Jan; 18 Suppl 4():S62-8. PubMed ID: 1721982 [Abstract] [Full Text] [Related]
6. Effects of carvedilol on blood pressure in patients with mild to moderate hypertension. A dose response study. McPhillips JJ, Schwemer GT, Scott DI, Zinny M, Patterson D. Drugs; 1988 Jan; 36 Suppl 6():82-91. PubMed ID: 2908306 [Abstract] [Full Text] [Related]
8. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension. Wong GW, Laugerotte A, Wright JM. Cochrane Database Syst Rev; 2015 Aug 26; 2015(8):CD007449. PubMed ID: 26306578 [Abstract] [Full Text] [Related]
9. Controlled-release carvedilol in the treatment of essential hypertension. Weber MA, Sica DA, Tarka EA, Iyengar M, Fleck R, Bakris GL. Am J Cardiol; 2006 Oct 02; 98(7A):32L-38L. PubMed ID: 17023230 [Abstract] [Full Text] [Related]
10. Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension. Ollivier JP, Durier P, Bussiere JL, Gayet JL. Eur J Clin Pharmacol; 1990 Oct 02; 38 Suppl 2():S164-6. PubMed ID: 1974509 [Abstract] [Full Text] [Related]
11. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey. Mori Y, Nishikawa Y, Iizuka T, Zenimura N, Matsumoto T, Hiramatsu K, Komiya M. Drugs R D; 2011 Oct 02; 11(2):171-90. PubMed ID: 21679007 [Abstract] [Full Text] [Related]
13. Comparison of the effects of carvedilol and nifedipine in patients with essential hypertension and non-insulin-dependent diabetes mellitus. Albergati F, Paternó E, Venuti RP, Boeri D, Lombardo I, Semino S, Viviani GL, Adezati L. J Cardiovasc Pharmacol; 1992 Oct 02; 19 Suppl 1():S86-9. PubMed ID: 1378156 [Abstract] [Full Text] [Related]
14. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure. Lund-Johansen P, Omvik P, Nordrehaug JE, White W. J Cardiovasc Pharmacol; 1992 Oct 02; 19 Suppl 1():S27-34. PubMed ID: 1378146 [Abstract] [Full Text] [Related]
15. Effect of long-term carvedilol therapy on renal function in essential hypertension. Tomita K, Marumo F. J Cardiovasc Pharmacol; 1992 Oct 02; 19 Suppl 1():S97-101. PubMed ID: 1378158 [Abstract] [Full Text] [Related]
20. Efficacy of carvedilol in mild to moderate essential hypertension and effects on microalbuminuria: a multicenter, randomized, open-label, controlled study versus atenolol. Marchi F, Ciriello G. Adv Ther; 1995 Oct 02; 12(4):212-21. PubMed ID: 10155349 [Abstract] [Full Text] [Related] Page: [Next] [New Search]